Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...

JCPenney and Ashley Graham defy the Ozempic trend with a bold, size-inclusive campaign that celebrates curves and drives ...

Fans are speculating about Demi Lovato’s look after her latest appearances. See Demi’s 2025 transformation photos ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

Eli Lilly stock rose early Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest ...

Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.

A groundbreaking study has compared the three top weight loss medications on the market, which has produced some surprising ...

By Maggie Fick LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an ...

Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U. obesity ...

Pfizer reportedly plans to claim that Novo’s bid doesn’t qualify as "superior" to Pfizer’s agreed $7 billion deal and skirts ...

Two of the world’s largest pharmaceutical companies are locked in a bidding war for the maker of a weight-loss drug that ...

Roblox posted a wider third-quarter loss but boosted its revenue forecast for the year as a pair of videogaming crazes generated robust top-line growth. Fox logged higher revenue in its fiscal first ...